Letter: On the edge of public service

Since its founding in 2016, Exante Data has been focussed on serving the world’s most sophisticated investors. 

But 2020 has been no normal year. Since late January, we have increasingly directed our entire team effort on analyzing the evolution of COVID.

Since epidemiology is not our core expertise, we have tried to add value in the intersection between data tracking / modelling and the impact on markets and the economy. It is in this multidisciplinary space that we typically add the most value.

But our research has also edged closer to public service than is normal for us:

– Top epidemiologists from Imperial College published a paper this week using Exante’s data on people movement in China; to test whether COVID can remain contained in the face of economic normalization there.

– Grant Wilson (Exante’s Head of Asia-Pac) has written a series of influential op-eds on COVID for the Australia Financial Review, and he was called on to brief the Standing Committee of Economics yesterday in Canberra.

– We have added government officials and health experts to our daily COVID update, on a pro bono basis.

– We have made a number of our metrics of social distancing publicly available on our twitter feed @exantedata, as a free service for the broader public, including policy makers and business managers, who are suddenly seeking insights from our alternative data.

This is not a normal time. and we are adapting accordingly. We are trying to do ‘the right thing’, while at the same time running a commercial business. In parallel, we are learning that remote working actually brings the team closer together, and we are also feeling more closely connected with our clients than ever before. So that is a silver-lining, if there is one.

If you think we can help, just reach out, and we will try.

Jens Nordvig
Founder & CEO
Exante Data Inc.


Exante Data © 2021. All rights reserved. Personal Data Usage Policy

This site is provided for informational purposes only.  The information included in this site should not be used as the sole basis for making a decision as to whether or not to invest in any particular security. In making an investment decision, you must rely on your own examination of the securities and the terms of the offering. You should not construe the contents of these materials as legal, tax, investment or other advice, or a recommendation to purchase or sell any particular security.

The information included in this site is based upon information reasonably available to Exante as of the date noted herein. Furthermore, the information included in this site has been obtained from sources that Exante believes to be reliable; however, these sources cannot be guaranteed as to their accuracy or completeness. Information contained in this site does not purport to be complete, nor does Exante undertake any duty to update the information set forth herein. No representation, warranty or undertaking, express or implied, is given as to the accuracy or completeness of the information contained herein, by Exante, its members, partners or employees, and no liability is accepted by such persons for the accuracy or completeness of any such information.

This site contains certain “forward-looking statements,” which may be identified by the use of such words as “believe,” “expect,” “anticipate,” “should,” “planned,” “estimated,” “potential,” “outlook,” “forecast,” “plan” and other similar terms. Examples of forward-looking statements include, but are not limited to, estimates with respect to financial condition, results of operations, and success or lack of success of certain investment strategy. All are subject to various factors, including, but not limited to, general and local economic conditions, changing levels of competition within certain industries and markets, changes in interest rates, changes in legislation or regulation, and other economic, competitive, governmental, regulatory and technological factors affecting the operations of the companies identified herein, any or all of which could cause actual results to differ materially from projected results.

Get more information about Exante Data
Get Ahead With Our Updates with Our Exante Newsletter